Industries > Pharma > Global Neurovascular Devices Market Forecast to 2027

Global Neurovascular Devices Market Forecast to 2027

Cerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Support Devices, Neurothrombectomy Devices

PUBLISHED: 11 January 2018
PAGES: 152
PRODUCT CODE: PHA0274

Clear
WOOCS 2.2.1

The global neurovascular devices market is expected to grow at a CAGR of 10.3% in the first half of the forecast period. In 2016, the Cerebral Embolization and Aneurysm Coiling Devices segment held the largest share in the global neurovascular devices market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 152-page report you will receive 85 charts– all unavailable elsewhere.

The 152-page report provides clear detailed insight into the global neurovascular devices market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Global Neurovascular Devices Market Forecast to 2027

Report Scope

• Global Neurovascular Devices market forecasts to 2027

• This report also breaks down the revenue forecast for the global neurovascular market by submarket
– Cerebral Embolization and Aneurysm Coiling Devices
– Cerebral Angioplasty and Stenting Systems
– Support Devices
– Neurothrombectomy Devices

• This report provides individual revenue forecasts to 2027 for these regional and national markets:
– The US
– EU5: Germany, France, the UK, Italy, Spain
– Japan
– BRIC: Brazil, Russia, India, China
– Rest of the World (RoW)

• Our study gives qualitative analysis of the neurovascular devices market. It discusses the SWOT analysis of the neurovascular devices market.

• Our study discusses the selected leading companies that are the major players in the neurovascular devices industry:
– Stryker Corporation
– Medtronic
– Johnson & Johnson
– Terumo
– Penumbra

Visiongain’s study is intended for anyone requiring commercial analyses for the global b neurovascular devices market. You find data, trends and predictions.

Buy our report today Global Neurovascular Devices Market Forecast to 2027: Cerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Support Devices, Neurothrombectomy Devices.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Neurovascular Devices Market Forecast to 2027


Download sample pages

Complete the form below to download your free sample pages for Global Neurovascular Devices Market Forecast to 2027


Latest Pharma news

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

READ

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

READ

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

READ

Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021

READ

Categories